Evolent Health (EVH) Reports Next Week: What to Know Ahead of the Release

Core Viewpoint - The market anticipates Evolent Health (EVH) to report flat earnings of $0.30 per share for the quarter ended September 2024, with revenues expected to rise by 22.4% to $625.58 million compared to the previous year [1][3]. Earnings Expectations - The upcoming earnings report is scheduled for November 7, and the stock may experience upward movement if actual results exceed expectations, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised down by 2.4% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a positive Earnings ESP of +13.33% for Evolent Health, suggesting analysts have recently become more optimistic about the company's earnings prospects [10]. - Despite the positive Earnings ESP, the stock holds a Zacks Rank of 4, complicating predictions of an earnings beat [10]. Historical Performance - Evolent Health has a history of beating consensus EPS estimates, having surpassed expectations in the last four quarters, including a +42.86% surprise in the most recent quarter [11][12]. Industry Comparison - Clarivate PLC (CLVT), another player in the Zacks Internet - Software industry, is expected to report earnings of $0.19 per share, reflecting a year-over-year decline of 9.5% [16]. - Clarivate's consensus EPS estimate has been revised down by 1.1%, but a higher Most Accurate Estimate results in a positive Earnings ESP of 2.15%, indicating a likely earnings beat [17].